
Mosie Baby
Mosie Baby is "home" fertility company and home to "Mosie" - the first MD endorsed, patent-pending syringe designed for women by women specifically for at-home insemination.
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 17 % | - |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Mosie Baby operates in the fertility and reproductive health market, offering a unique home insemination kit designed to assist individuals and couples trying to conceive. The core product, the Mosie Kit, includes a patent-pending syringe specifically engineered for home insemination, which maximizes sperm release and minimizes waste. This product is particularly beneficial for those who find timed intercourse challenging or ineffective. The company primarily serves individuals and couples looking for an affordable, simple, and clinically proven alternative to traditional intrauterine insemination (IUI) procedures. Mosie Baby generates revenue through direct sales of its kits via its website, targeting a niche market of consumers seeking fertility solutions outside of clinical settings. The business model focuses on e-commerce, leveraging online marketing and customer testimonials to drive sales.
Keywords: fertility, home insemination, Mosie Kit, reproductive health, patent-pending syringe, conception aid, affordable alternative, e-commerce, direct sales, fertility solutions.